Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B
Clinical trial NCT07673068 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07673068
- Sponsor
- Grand Theravac Life Sciences (Nanjing) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2027-05-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.